MaƱacap, Elvie R.
HRN: 24-18-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
CEFTAZIDIME 1GM (VIAL)
11/29/2023
12/05/2023
IV
2grams
Q8
Infected Wound, Left, Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes